Pregnant women with congenital heart disease (CHD) who have not had surgery to repair their cardiac condition are more likely to experience cardiac events or maternal death, especially those with certain conditions in emerging countries, according to a study published Oct. 9 in JACC: Heart Failure.
Researchers examined 5,739 pregnancies in 53 countries. A total of 3,295 women had CHD, with 1,059 uncorrected. Of these, 41.4 percent were from emerging countries. There were marked differences in cardiac defects in uncorrected versus corrected CHD with primary shunt lesions (44.7 percent vs 32.4 percent), valvular abnormalities (33.5 percent vs 12.6 percent) and Tetralogy of Fallot/Pulmonary atresia (0.8 percent vs 20.3 percent), p<0.001. In uncorrected CHD 6.8 percent were in mWHO risk class IV, about 10 percent had pulmonary hypertension (PH) and 3 percent were cyanotic prior to pregnancy. Maternal mortality and heart failure (HF) in the women with uncorrected CHD were 0.7 percent and 8.7 percent, respectively. Eisenmenger syndrome, or abnormal blood circulation usually caused by a hole between heart chambers, was associated with a very high risk of cardiac events (65.5 percent), maternal mortality (10.3 percent) and HF (48.3 percent). Coming from an emerging country was associated with higher pre-pregnancy signs of HF, PH and cyanosis (p<0.001) and worse maternal and fetal outcomes, with a threefold higher rate of hospital admissions for cardiac events and slow intrauterine growth (p<0.001).
“This analysis of a large, prospective contemporary global cohort of women presenting with uncorrected CHD highlights a different disease profile and more complicated disease at presentation, compared to women who had access to cardiac interventions,” the authors write. “This information will provide some guidance to physicians who care for those patients and may alert them to potential risks.”
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its more than 52,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit
Journal of the American College of Cardiology
ranks among the top cardiovascular journals in the world for its scientific impact. JACC is the flagship for a family of journals–
JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology, JACC: Basic to Translational Science, JACC: Case Reports and JACC: CardioOncology
–that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at
This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-10/acoc-uch100719.php